Focus:
Nephrology & Urology
-
23 October 2019 Company News
US biomedical engineer gets NIH award for prostate cancer system
A biomedical engineer at Worcester Polytechnic Institute (WPI) in the US has received a five-year award from the National Institute of Health for his ongoing work on an MRI-guided robotic...
-
14 August 2019 Analysis
At-home haemodialysis: a thriving investment trend
Home haemodialysis machines are understandably popular with chronic end-stage kidney failure patients. As the Trump administration promises to bolster kidney care in the US, how is this growing market developing?
-
6 August 2019 News
RenalSense secures CE Mark approval for Clarity RMS technology
RenalSense has obtained CE Mark approval for its Clarity RMS critical care system for real-time monitoring of urine flow in the critical care and peri-operative setting.
-
17 July 2019 News
First participant enrolled in FemPulse overactive bladder study
Bioelectronic medicine company FemPulse has enrolled its first participant in a clinical trial evaluating physiological responses to its overactive bladder (OAB) technology.
-
16 July 2019 News
3D-printed models used to plan kidney cancer surgery
Full-colour, multi-material 3D printing technology is helping surgeons at Bordeaux University Hospital (CHU) improve the planning of complex kidney tumour removal surgery.
-
24 June 2019 News
CMR Surgical and LifeHealthcare bring Versius robotic surgery to Australia
CMR Surgical and LifeHealthcare are teaming up to bring the Versius robotic keyhole surgery system to Australia and New Zealand.
-
28 January 2019 News
Researchers create bladder cancer urine test
Researchers at the Stanford University School of Medicine in the US have developed a highly sensitive urine test to diagnose and monitor bladder cancer.
-
15 November 2018 pressreleases
Teampac Boosts its Talent for Helping Brands Grow
Teampac has appointed Carl Fagerudd to the position of sales director, as the company continues to develop its offering for healthcare products and to strengthen its solution-oriented customer care.
-
18 October 2018 News
Boston Scientific concludes Augmenix acquisition
US-based Boston Scientific has completed the acquisition of Augmenix for an upfront cash consideration of $500m.
-
24 September 2018 News
Boston Scientific introduces new ureteroscopy device
Boston Scientific has launched the LithoVue Empower Retrieval Deployment Device in the US and Europe for retrieval of kidney stones through flexible ureteroscopy (URS).